J. Molner AS
JML | Nasdaq Baltic
Overview
Corporate Details
- ISIN(s):
- EE3100109034
- LEI:
- 984500F0KEF52E642E45
- Country:
- Estonia
- Address:
- Akadeemia tee 21/5, 12618 Tallinn
- Website:
- https://www.jmolner.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Located in Northern Europe in Estonia, The J. Molner Company's main laboratory was originally founded in 2015 as part of a global pharmaceutical company to accelerate research and development activities. With a focus on sterile injectable and dermatological drugs for both the United States and Canada, our team has developed a GMP certified facility that provides services to pharmaceutical companies looking to grow their pipelines and manage costs by leveraging our capabilities.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
GNI Group Ltd. | Japan | 2160 | |
|
Gour Medical | France | MLGML | |
|
Grifols S.A. | Spain | GRF | |
|
Grindeks | Latvia | GRD1R | |
|
Guerbet | France | GBT | |
|
Haemato AG | Germany | HAEK | |
|
Halychpharm | Ukraine | GFARM | |
|
Hamlet BioPharma AB | Sweden | HAMLET | |
|
Harm Reduction Group AB | Sweden | NOHARM | |
|
HEALIOS K.K. | Japan | 4593 |